0.3 |
0.8 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 |
0.7 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
0.2 |
0.6 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 |
0.6 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 |
1.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
0.2 |
0.2 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
0.1 |
0.4 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
0.1 |
1.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 |
0.7 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
0.1 |
0.7 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 |
0.4 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
0.1 |
0.3 |
GO:2000564 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) CD8-positive, alpha-beta T cell proliferation(GO:0035740) negative regulation of regulatory T cell differentiation(GO:0045590) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.1 |
0.4 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 |
0.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 |
0.6 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 |
0.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
0.1 |
1.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
0.1 |
0.8 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.1 |
0.3 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
0.1 |
0.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
0.1 |
0.5 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
0.1 |
0.3 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
0.1 |
0.4 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
0.1 |
0.2 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
0.1 |
0.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
0.1 |
0.3 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 |
0.3 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
0.1 |
0.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
0.1 |
0.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 |
0.2 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 |
0.2 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.1 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
0.1 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
0.1 |
0.2 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 |
0.3 |
GO:0042891 |
antibiotic transport(GO:0042891) |
0.1 |
0.4 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
0.1 |
0.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 |
0.5 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 |
0.4 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
0.0 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 |
0.3 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 |
0.2 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
0.0 |
0.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
0.0 |
0.5 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
0.0 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.0 |
0.4 |
GO:0030432 |
peristalsis(GO:0030432) |
0.0 |
0.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.0 |
0.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.0 |
0.3 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
0.0 |
0.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.0 |
0.2 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 |
0.0 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
0.0 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 |
0.4 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
0.0 |
0.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
0.0 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 |
0.3 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 |
0.1 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.0 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
0.0 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
0.0 |
0.3 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 |
0.9 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.0 |
0.5 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
0.0 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
0.0 |
0.1 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
0.0 |
0.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
0.0 |
0.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 |
0.1 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
0.0 |
0.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
0.0 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
0.0 |
0.7 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
0.0 |
0.3 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
0.0 |
0.3 |
GO:1901629 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) regulation of presynaptic membrane organization(GO:1901629) |
0.0 |
0.4 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
0.0 |
0.1 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 |
0.0 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
0.0 |
0.1 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 |
0.4 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
0.0 |
0.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 |
0.5 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 |
0.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 |
1.9 |
GO:0051592 |
response to calcium ion(GO:0051592) |
0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 |
0.2 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
0.0 |
0.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
0.0 |
0.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
0.0 |
0.0 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 |
0.0 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 |
0.1 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.0 |
0.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 |
0.4 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
0.0 |
0.2 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 |
0.1 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.0 |
0.0 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.0 |
0.1 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 |
0.0 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
0.0 |
0.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 |
0.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
0.0 |
0.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
0.0 |
0.5 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
0.0 |
0.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 |
0.3 |
GO:0003016 |
respiratory system process(GO:0003016) |
0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
0.0 |
0.7 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
0.0 |
0.2 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 |
0.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 |
0.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
0.0 |
0.1 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
0.0 |
0.1 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 |
0.1 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 |
0.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
0.0 |
0.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
0.0 |
0.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
0.0 |
0.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
0.0 |
0.1 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
0.0 |
0.1 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
0.0 |
0.1 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |